Welcome : Guest

Corbus Pharmaceuticals Holdings, Inc. (USA) - Facts, Figures and Analytical Insights


This report presents quick facts about Corbus Pharmaceuticals Holdings, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 5 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64129
Price: $250
Company Type: Public
Pages: 7
Date: November 2016
Market Data Tables: 5

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Cystic Fibrosis (CF)......3
Table 1: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2015) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......3
Table 2: Drugs for Treatment of Cystic Fibrosis Market Worldwide (2015) in US$ Million......4
Rheumatology Drugs......5
Table 3: Rheumatology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others......5
Systemic Lupus Erythematosus with Benlysta......6
Table 4: Systemic Lupus Erythematosus with Benlysta Market by Category in the US (2015) - Percentage Share Breakdown by Value for Mild Systemic Lupus Erythematosus (excluded in target population), Moderate Systemic Lupus Erythematosus, and Severe Systemic Lupus Erythematosus......6
Table 5: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......7